Role of kinin B1 and B2 receptors in memory consolidation during the aging process of mice

Neuropeptides

Volumn 44, Issue 2, 2010, Pages 163-168

  Lemos, Mayra Tolentino Resk ^a   Amaral, Fabio Agostini ^a   Dong, Karis Ester ^a   Bittencourt, Maria Fernanda Queiroz Prado ^a   Caetano, Ariadiny Lima ^a   Pesquero, João Bosco ^c   Viel, Tania Araujo ^b   Buck, Hudson Sousa ^a  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aging; Elderly; Kallikrein; Kinin receptors; Learning; Memory

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; C57BL 6 MOUSE; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; KNOCKOUT MOUSE; LEARNING; LONG TERM MEMORY; MEMORY CONSOLIDATION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE RESEARCH; TASK PERFORMANCE; WILD TYPE;

AGE FACTORS; AGING; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; EXPLORATORY BEHAVIOR; MALE; MEMORY; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2;

ANIMALIA; MUS;

EID: 77049124982     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2009.12.006     Document Type: Article

References (40)

1. Amaral F.A., Lemos M.T.R., Dong K.E., Bittencourt M.F.Q.P., Caetano A.L., Pesquero J.B., Viel T.A., and Buck H.S. Participation of kinin receptors on memory impairment after chronic infusion of human amyloid-β 1-40 (A β) peptide in mice. Neuropeptides 44 2 (2010) 93-97
2. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44 1 (1992) 1-80
3. Boix F., Rosenborg L., Hilgenfeldt U., and Knardahl S. Contraction-related factors affect the concentration of a kallidin-like peptide in rat muscle tissue. J. Physiol. 544 Pt 1 (2002) 127-136
4. Bovenzi V., Savard M., Morin J., Cuerrier C.M., Grandbois M., and Gobeil F.Jr. Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli. J. Cell. Physiol. 222 1 (2010) 168-176
5. Buck H.S., Ongali B., Thibault G., Lindsey C.J., and Couture R. Autoradiographic detection of kinin receptors in the human medulla of control, hypertensive, and diabetic donors. Can. J. Physiol. Pharmacol. 80 4 (2002) 249-257
6. Cloutier F., Ongali B., Campos M.M., Thibault G., Neugebauer W., and Couture R. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats. Br. J. Pharmacol. 142 2 (2004) 285-296
7. Conde J.R., and Streit W.J. Microglia in the aging brain. J. Neuropathol. Exp. Neurol. 65 3 (2006) 199-203
8. Couture R., and Lindsey C.J. Brain kallikrein-kinin system: from receptors to neuronal pathways and physiological functions. In: Quirion R., Björklund, and Hökfelt T. (Eds). Handbook of Chemical Neuroanatomy vol. 16 (2000), Elsevier Science B.V. 241-300
9. Erdös E., and Skidgel R. Metabolism of bradykinin by peptidases in health and disease. In: Farmer S. (Ed). The kinin system (1997), Academic Press, San Diego 111-141
10. Hein A.M., and O'Banion M.K. Neuroinflammation and memory: the role of prostaglandins. Mol. Neurobiol. 40 1 (2009) 15-32
11. Iores-Marçal L.M., Viel T.A., Buck H.S., Nunes V.A., Gozzo A.J., Cruz-Silva I., Miranda A., Shimamoto K., Ura N., and Araujo M.S. Bradykinin release and inactivation in brain of rats submitted to an experimental model of Alzheimer's disease. Peptides 27 12 (2006) 3363-3369
12. Jenkins D.W., Sellers L.A., Feniuk W., and Humphrey P.P. Characterization of bradykinin-induced prostaglandin E2 release from cultured rat trigeminal ganglion neurones. Eur. J. Pharmacol. 469 1-3 (2003) 29-36
13. Kozlowski M.R., Rosser M.P., and Hall E. Identification of 3Hbradykinin binding sites in PC-12 cells and brain. Neuropeptides 12 (1988) 207-211
14. Langberg H., Bjørn C., Boushel R., Hellsten Y., and Kjaer M. Exercise-induced increase in interstitial bradykinin and adenosine concentrations in skeletal muscle and peritendinous tissue in humans. J. Physiol. 542 Pt 3 (2002) 977-983
15. Leeb-Lundberg L.M.F., Marceau F., Müller-Esterl W., Pettibone D.J., and Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57 (2005) 27-77
16. Lim S.K., Park M.J., Jung H.K., Park A.Y., Kim D.I., Kim J.C., Bae C.S., Kim K.Y., Yoon K.C., Han H.J., and Park S.H. Bradykinin stimulates glutamate uptake via both B1R and B2R activation in a human retinal pigment epithelial cells. Life Sci. 83 23-24 (2008) 761-770
17. Marceau F., Larrivée J.F., Saint-Jacques E., and Bachvarov D.R. The kinin B1 receptor: an inducible G protein coupled receptor. Can. J. Physiol. Pharmacol. 75 6 (1997) 725-730
18. Mayhan W.G. Regulation of blood-brain barrier permeability. Microcirculation 8 2 (2001) 89-104
19. McGaugh J.L. Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu. Rev. Neurosci. 12 (1989) 255-287
20. McGeer E.G., and McGeer P.L. Inflammatory processes in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 741-749
21. Medina J.H., Bekinschtein P., Cammarota M., and Izquierdo I. Do memories consolidate to persist or do they persist to consolidate?. Behav. Brain Res. 192 1 (2008) 61-69
22. Miller K.R., and Streit W.J. The effects of aging, injury and disease on microglial function: a case for cellular senescence. Neuron Glia Biol. 3 (2007) 245-253
23. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11 (1984) 47-60
24. Noda M., Sasaki K., Ifuku M., and Wada K. Multifunctional effects of bradykinin on glial cells in relation to potential anti-inflammatory effects. Neurochem. Int. 51 (2007) 185-191
25. Noda M., Kariura Y., Pannasch U., Nishikawa K., Wang L., Seike T., Ifuku M., Kosai Y., Wang B., Nolte C., Aoki S., Kettenmann H., and Wada K. Neuroprotective role of bradykinin because of the attenuation of proinflammatory cytokine release from activated microglia. J. Neurochem. 101 (2007) 397-410
26. Prat A., Biernacki K., Pouly S., Nalbantoglu J., Couture R., and Antel J.P. Kinin B1 receptor expression and function on human brain endothelial cells. J. Neuropathol. Exp. Neurol. 59 (2000) 896-906
27. Prat A., Weinrib L., Becher B., Poirier J., Duquette P., Couture R., and Antel J.P. Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis. Neurology 53 (1999) 2087-2092
28. Prediger R.D., Medeiros R., Pandolfo P., Duarte F.S., Passos G.F., Pesquero J.B., Campos M.M., Calixto J.B., and Takahashi R.N. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease. Neuroscience 151 3 (2008) 631-643
29. Quillfeldt J.A., Zanatta M.S., Schmitz P.K., Quevedo J., Schaeffer E., Lima J.B., Medina J.H., and Izquierdo I. Different brain areas are involved in memory expression at different times from training. Neurobiol. Learn. Mem. 66 2 (1996) 97-101
30. Raidoo D.M., and Bhoola K.D. Pathophysiology of the Kalikrein-Kinin system in mammalian nervous tissue. Pharmacol. Ther. 79 2 (1998) 105-127
31. Raidoo D.M., and Bhoola K.D. Kinin receptors on human neurons. J. Neuroimmunol. 77 (1997) 39-44
32. Regoli D., and Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32 1 (1980) 1-46
33. Salminen A., Ojala J., Kauppinen A., Kaarniranta K., and Suuronen T. Inflammation in Alzheimer's disease: Amyloid-b oligomers trigger innate immunity defense via pattern recognition receptors. Prog. Neurobiol. 87 (2009) 181-194
34. Shirotani K., Tsubuki S., Iwata N., Takaki Y., Harigaya W., Maruyama K., Kiryu-Seo S., Kiyama H., Iwata H., Tomita T., Iwatsubo T., and Saido T.C. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan-and phosphoramidon-sensitive endopeptidases. J. Biol. Chem. 276 24 (2001) 21895-21901
35. Steranka L.R., Manning D.C., DeHaas C.J., Ferkany J.W., Borosky S.A., Connor J.R., Vavrek R.J., Stewart J.M., and Snyder S.H. Bradykinin as a pain mediator: Receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc. Natl. Acad. Sci. 85 (1988) 3245-3249
36. Turner A.J., Fisk L., and Nalivaeva N.N. Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration. Ann. N. Y. Acad. Sci. 1035 (2004) 1-20
37. Viel T.A., Caetano A.L., Nasello A.G., Lancelotti C.L., Nunes V.A., Araujo M.S., and Buck H.S. Increases of kinin B(1) and B(2) receptors binding sites after brain infusion of amyloid-beta 1-40 peptide in rats. Neurobiol. Aging 29 (2008) 1805-1814
38. Walther T., Albrecht D., Becker M., Schubert M., Kouznetsova E., Wiesner B., Maul B., Schliebs R., Grecksch G., Furkert J., Sterner-Kock A., Schultheiss H.P., Becker A., and Siems W.E. Improved learning and memory in aged mice deficient in amyloid beta-degrading neutral endopeptidase. PLoS One 4 2 (2009) e4590
39. Wang Q., and Wang J. Injection of bradykinin or cyclosporine A to hippocampus induces Alzheimer-like phosphorylation of Tau and abnormal behavior in rats. Chin. Med. J. 115 6 (2002) 884-887
40. Yasuyoshi H., Kashii S., Zhang S., Nishida A., Yamauchi T., Honda Y., Asano Y., Sato S., and Akaike A. Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neurons. Invest. Ophthalmol. Vis. Sci. 41 8 (2000) 2273-2278